ISIS 396443
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ISIS 396443, covering 2020-01-27 to 2020-01-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA). [Phase 2]